|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 534.47 USD | -1.83% |
|
+1.63% | +14.48% |
| Capitalization | 119B 103B 93.57B 89.83B 164B 10,972B 171B 1,107B 442B 5,257B 448B 439B 18,851B | P/E ratio 2026 * |
17.6x | P/E ratio 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise value | 167B 144B 131B 125B 229B 15,319B 239B 1,546B 618B 7,340B 626B 613B 26,319B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.99x |
| Free-Float |
71.58% | Yield 2026 * |
0.57% | Yield 2027 * | 0.6% |
Last Transcript: HCA Healthcare, Inc.
| 1 day | -1.83% | ||
| 1 week | +1.63% | ||
| Current month | +0.90% | ||
| 1 month | +4.03% | ||
| 3 months | +9.82% | ||
| 6 months | +27.02% | ||
| Current year | +14.48% |
| 1 week | 524.1 | 547.43 | |
| 1 month | 495 | 552.9 | |
| Current year | 461.44 | 552.9 | |
| 1 year | 310.18 | 552.9 | |
| 3 years | 215.96 | 552.9 | |
| 5 years | 164.47 | 552.9 | |
| 10 years | 58.38 | 552.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samuel Hazen
CEO | Chief Executive Officer | 64 | 01/01/2019 |
Mike Marks
DFI | Director of Finance/CFO | 56 | 01/05/2024 |
Jon Foster
PSD | President | 63 | 01/10/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Frist
CHM | Chairman | 58 | 26/04/2019 |
William Frist
BRD | Director/Board Member | 56 | 01/01/2009 |
Samuel Hazen
BRD | Director/Board Member | 64 | 10/09/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.83% | +1.63% | +67.22% | +113.80% | 122B | ||
| -2.33% | +0.87% | +19.32% | -3.81% | 103B | ||
| -3.69% | -9.20% | +17.74% | +86.27% | 31.56B | ||
| -1.76% | -4.07% | +8.51% | +15.28% | 23.14B | ||
| -2.14% | -3.37% | +18.59% | +44.87% | 22.9B | ||
| -0.25% | +2.86% | -12.00% | -1.00% | 22.21B | ||
| -1.39% | +0.72% | +91.56% | +294.44% | 21.29B | ||
| -3.03% | -8.23% | +41.33% | +64.99% | 16.63B | ||
| +1.40% | +3.82% | -7.78% | +8.17% | 12.52B | ||
| -2.64% | -3.61% | +10.83% | +54.94% | 12.36B | ||
| Average | -1.30% | -2.44% | +25.53% | +67.80% | 38.68B | |
| Weighted average by Cap. | -0.75% | -0.86% | +35.54% | +66.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.68B 68.05B 61.62B 59.16B 108B 7,226B 113B 729B 291B 3,462B 295B 289B 12,414B | 82.51B 71.35B 64.61B 62.03B 113B 7,577B 118B 764B 305B 3,630B 310B 303B 13,017B |
| Net income | 6.82B 5.9B 5.34B 5.13B 9.36B 627B 9.77B 63.23B 25.27B 300B 25.62B 25.07B 1,077B | 7.14B 6.18B 5.6B 5.37B 9.8B 656B 10.23B 66.2B 26.45B 314B 26.82B 26.24B 1,127B |
| Net Debt | 47.33B 40.93B 37.07B 35.59B 64.91B 4,347B 67.77B 439B 175B 2,083B 178B 174B 7,468B | 45B 38.92B 35.24B 33.84B 61.71B 4,133B 64.43B 417B 167B 1,980B 169B 165B 7,100B |
Employees
275,000
Calendar
03-17 -
Ex-dividend date - 0.78 USD
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/03/26 | 534.47 $ | -1.83% | 1,097,839 |
| 04/03/26 | 544.41 $ | +0.48% | 930,563 |
| 03/03/26 | 541.80 $ | +1.67% | 797,639 |
| 02/03/26 | 532.92 $ | +0.61% | 816,440 |
| 27/02/26 | 529.70 $ | +0.73% | 2,291,545 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
534.47USD
Average target price
541.52USD
Spread / Average Target
+1.32%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















